PHVS (NASDAQ: PHVS) insider plans to sell 15,000 shares after option exercise

Rhea-AI Filing Summary

PHVS files a Form 144 reporting proposed sale of 15,000 shares of Common Stock. The filing states the shares relate to an exercise of stock options and are to be sold for cash on 06/25/2026. The excerpt also lists prior 10b5-1 sales in April–June 2026 totaling multiple transactions, including 14,166 and 15,000 share sales on 05/01/2026 and 04/30/2026, respectively.

Insights

Securities Compliance Analyst

Form 144 indicates a planned sale tied to option exercise under routine procedures.

The filing lists a proposed sale of 15,000 shares on 06/25/2026 following an exercise of stock options. It also documents multiple prior 10b5-1 sales in April–June 2026, which suggests the transactions are being executed under pre-established trading arrangements.

Timing and cash‑flow treatment are set as cash for the 06/25/2026 sale; subsequent disclosures or broker confirmations will report completed transactions.

Equity Capital Markets Specialist

Transaction pattern is consistent with option exercises followed by structured disposals.

The excerpt shows issuer-related exercise followed by planned sale of 15,000 shares. Prior sales include 15,000 and 14,166 share dispositions under a 10b5-1 plan, with gross proceeds listed per trade.

These filings are administrative notifications; actual market impact depends on execution details and timing recorded after settlement.

Key Figures

Proposed sale: 15,000 shares Prior sale (May 1, 2026): 14,166 shares Prior sale (Apr 30, 2026): 15,000 shares +3 more

6 metrics

Proposed sale 15,000 shares to be sold on 06/25/2026 after exercise of stock options

Prior sale (May 1, 2026) 14,166 shares 10b5-1 sale on 05/01/2026 with $427,417.97 gross proceeds

Prior sale (Apr 30, 2026) 15,000 shares 10b5-1 sale on 04/30/2026 with $453,627.00 gross proceeds

Prior sale (Apr 29, 2026) 3,733 shares 10b5-1 sale on 04/29/2026 with $112,232.27 gross proceeds

Prior sale (Apr 22, 2026) 7,001 shares 10b5-1 sale on 04/22/2026 with $210,401.75 gross proceeds

Small sale (Jun 18, 2026) 300 shares 10b5-1 sale on 06/18/2026 with $10,200.00 gross proceeds

Key Terms

Form 144, 10b5-1, Exercise of Stock Options

3 terms

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

10b5-1 regulatory

"10b5-1 Sales for PENG LU ... | Common | 05/01/2026"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Exercise of Stock Options financial

"Securities To Be Sold | Exercise of Stock Options | Issuer"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 06/25/2026 - 04:25 PM Accepted by SEC EDGAR 06/25/2026 - 04:25 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	15000	499350.00	65210590	06/25/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/25/2026	Exercise of Stock Options	Issuer			15000	06/25/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for PENG LU Emmy Noetherweg 2 Leiden P7 2333 BK	Common	06/18/2026	300	10200.00
10b5-1 Sales for PENG LU Emmy Noetherweg 2 Leiden P7 2333 BK	Common	05/01/2026	14166	427417.97
10b5-1 Sales for PENG LU Emmy Noetherweg 2 Leiden P7 2333 BK	Common	04/30/2026	15000	453627.00
10b5-1 Sales for PENG LU Emmy Noetherweg 2 Leiden P7 2333 BK	Common	04/29/2026	3733	112232.27
10b5-1 Sales for PENG LU Emmy Noetherweg 2 Leiden P7 2333 BK	Common	04/23/2026	100	3003.00
10b5-1 Sales for PENG LU Emmy Noetherweg 2 Leiden P7 2333 BK	Common	04/22/2026	7001	210401.75

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)